A Mason Engineering researcher has discovered that artificial microswimmers accumulate where their speed is minimized, an idea that could have implications for improving the efficacy of targeted cancer...

In a major advance in the treatment of multiple myeloma, a CAR T-cell therapy has generated deep, sustained remissions in patients who had relapsed from several previous therapies, an international clinical...

It’s the national record no one is celebrating: The American COVID-19 death toll has crossed the 500,000 mark. The novel coronavirus is now the third leading cause of death in the U.S....

Patients should be assessed for frailty before having many types of surgery, even if the surgery is considered low risk, a review of two national patient databases shows. Frailty is a clinical syndrome...

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. California is expanding its coronavirus vaccine program to include people aged 16-64...

The genomic landscape of circulating tumor DNA (ctDNA) was comparable to the landscape of tissue biopsies in a large study of patients with metastatic castration-resistant prostate cancer (mCRPC), according...

Endocrine therapy is standard of care for estrogen-receptor positive (ER+) breast cancer, but only about half of women respond. At present, there is no method for identifying the women who are likely —...

Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer survival than patients treated with the standard targeted drug, said...

A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy, according to new research from the Johns Hopkins...

A new aggressive surgery approach by the UCD Gynecological Oncology Group has helped improve the survival rates for women with ovarian cancer in Ireland. A study, published in the Annals of Surgical Oncology...